Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings Inc. is a biopharmaceutical company focused on the development and commercialization of innovative solutions utilizing its proprietary technology platforms. The primary function of Xeris is to address critical unmet needs in neurology, gastroenterology, and endocrinology through novel treatments that enhance patient care and convenience. A notable feature of Xeris's offerings is their pre-prepared, ready-to-use formulations that eliminate the need for intravenous or hospital-based care, thus facilitating easier administration and improving patient compliance. The company plays a pivotal role in the healthcare market by reducing the burden of chronic diseases and emergency situations through innovative drug delivery systems. Xeris's impact is particularly significant in sectors such as emergency medicine and chronic disease management, where immediacy and ease of access to medication are crucial. Its proprietary technologies enable the stabilization and reliable delivery of otherwise unstable compounds, significantly enhancing therapeutic outcomes. Headquartered in the United States, Xeris continues to expand its portfolio and global reach, aiming to transform the landscape of patient-centered therapeutics.